<?xml version="1.0" encoding="UTF-8" standalone="yes"?><Drug id="54784" name="drisapersen"><HDS>Discontinued</HDS><RegulatoryDesignations><RegulatoryDesignation id="3">Breakthrough Therapy</RegulatoryDesignation><RegulatoryDesignation id="2">Fast Track</RegulatoryDesignation><RegulatoryDesignation id="1">Orphan Drug</RegulatoryDesignation><RegulatoryDesignation id="13">Rare Pediatric Disease</RegulatoryDesignation></RegulatoryDesignations><Actions><Action id="20949" type="primary">DMD gene modulator</Action><Action id="26034" type="secondary">RNA interference agent</Action><Action id="7294" type="secondary">Antisense oligonucleotide inhibitor</Action></Actions><Indications><Indication id="2020" type="secondary">Duchenne dystrophy</Indication></Indications><Entities><Entity>Biological</Entity></Entities><OriginatorCompany id="27406">Leiden University Medical Center</OriginatorCompany></Drug>